Tickerplace logo

Tickerplace

Genmab A/S logo

GMABGenmab A/S

GMAB Stock Price, Valuation & Chart | Genmab A/S

Compare
$33.290+0.13 (+0.39%)

At close · 01 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyGMAB intrinsic valueGMAB calculated fair value vs price
OverviewFinancialsDividendsRatios

GMAB Historical price chart

GMAB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization20.44B
PE Ratio25.09
EPS1.33
Trading Volume1.56M
Today's High/Low33.69/33.14
Dividend Yield0.00
52 Week High/Low35.43/23.62
Shares Outstanding613.94M
GMAB Financial Statement
GMAB Analyst ratings
GMAB Analysis & performance metrics

GMAB Company profile

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for…

GMAB Management team

Management
Birgitte Stephensen M.Sc.
Executive Vice President & Chief Legal Officer
Tahamtan Ahmadi M.D., Ph.D.
Executive Vice President, Chief Medical Officer & Head of Experimental Medicines
Martine J. van Vugt Ph.D.
Executive Vice President & Chief Strategy Officer
Judith V. Klimovsky M.D.
Executive Vice President & Chief Development Officer
Jan G.J. van de Winkel Ph.D.CEO
Co-Founder, President & Chief Executive Officer
Christopher Cozic
Executive Vice President & Chief People Officer
Martin SchultzCTO
Senior Director of Clinical Operations & Non-Independent Director
Anthony Pagano CPACFO
Executive Vice President & Chief Financial Officer
Total 8 executives

GMAB Frequently asked questions

What is Genmab A/S (GMAB) Stock Price?

Current stock price of Genmab A/S (GMAB) stock is $33.290. The stock price is +0.39% higher in the session. The intraday range can be seen from this page. Volume of Genmab A/S (GMAB) stock is 1.56M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Genmab A/S (GMAB) stock price going up or down today?

The stock price of Genmab A/S (GMAB) can change with earnings, company news, and overall market sentiment. Genmab A/S operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Genmab A/S stock expensive at its current price?

Whether Genmab A/S looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GMAB on this page is 25.09. EPS on this page is 1.33. Compare those figures with peers and growth expectations before deciding if the current Genmab A/S price is justified.

How has the stock price of Genmab A/S (GMAB) performed historically?

Historical performance for Genmab A/S (GMAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GMAB reacted to past earnings and market events.

Should I buy Genmab A/S (GMAB) stock, at this price?

Buying Genmab A/S (GMAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.